Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano4Imaging has commercialized the EmeryGlide MRI-compatible guidewire with FDA clearance. Its TRACKR platform integrates proprietary MagnaFy nanocoatings for MR visibility of devices and AI-driven real-time tracking software. The company collaborates with leading hospitals in the US/EU and OEMs like Siemens Healthineers to develop new therapies in oncology, cardiovascular disease, and osteoarthritis. Clinical trials are ongoing to validate MRI-guided interventions as safer alternatives to X-ray-based methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano4Imaging.